Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about Psychedelic/Assisted Therapies
Recent news which mentions Psychedelic/Assisted Therapies
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Braxia Scientific's Q2 2024: Cash Burn Over But Income Low, What's Next For Psychedelics Company?
December 04, 2023
Tickers
BRAXF
TRUFF
Tags
Earnings
News
BRAXF
From
Benzinga
Super Model Chrissy Teigen Talks About Ketamine Therapy Session, Says She Saw 'Space & Time'
December 04, 2023
Tags
Markets
Cannabis
Market News
From
Benzinga
Cybin's Novel Psilocybin Topline Data: 79% Remission In Major Depression Symptoms, What's Next?
December 03, 2023
Tickers
CYBN
Tags
Psychedelics
Next/Generation Psychedelics
Benzinga
From
Benzinga
Red Light Holland, With $12M Cash Balance & Revenue Up 33%, Remains 'Confident' In Business Strategy
November 29, 2023
Tickers
TRUFF
Tags
psilocybin mushrooms
Benzinga
Global
From
Benzinga
Seelos Therapeutics' $5.55M Public Offering As Stock Drop 35%
November 29, 2023
Tickers
IPOS
SEEL
Tags
Public Offering
Markets
SEEL
From
Benzinga
Defense Dept. Funds Ketamine Study For PTSD Treatment In 600 Service Members & Veterans
November 27, 2023
Tickers
DOD
SEEL
Tags
Dr/ Raj Mehra
News
SEEL
From
Benzinga
Global Psychedelics: Norwegian User Trends & Finnish Interdisciplinary Conference
November 26, 2023
Tags
Psychedelics
Psychedelics Survey
Events
From
Benzinga
Global Psychedelics: Australia's Prescription Guidelines, New Zealand's Meth Addiction Treatment
November 24, 2023
Tags
MDMA treatment
Psilocybin program
Benzinga
From
Benzinga
Psyched: Ramaswamy Psychedelics For PTSD, UK Clinical Trials, Johns Hopkins Q&A And More
November 24, 2023
Tickers
ATAI
AWKNF
CMPS
CYBN
Tags
Psychedelics
AWKNF
DRUG
From
Benzinga
Clearmind Medicine's Reverse Stock Split And Nasdaq Delisting Notice
November 21, 2023
Tickers
CMND
Tags
Psychedelics
CMND
Next/Generation Psychedelics
From
Benzinga
Three Johns Hopkins Psychedelics Professors Call The Shots On Live Q&A: Knowns, Unknowns, Regulations & Hopes
November 20, 2023
Tags
Cannabis
Markets
Market News
From
Benzinga
UK Psychedelics: Phase 3 Depression & Alcohol Addiction Trials, New London Center
November 15, 2023
Tickers
AWKNF
CMPS
Tags
Penny Stocks
Psychedelic/Assisted Therapies
severe alcohol use disorder
From
Benzinga
GH Research: Steady Expenses And $229M Cash Position For 2026 Runway
November 14, 2023
Tickers
GHRS
Tags
financial results
Psychedelic/Assisted Therapies
GHRS
From
Benzinga
Atai Life Sciences' Q3 Earnings: Near $20M Burned QoQ, Says Funding 'Sufficient' To Streamline 2026
November 14, 2023
Tickers
ATAI
CMPS
Tags
CMPS
Next/Generation Psychedelics
ATAI
From
Benzinga
Psyched: Veterans & Psychedelics, $100M IPO, Cybin's $64M Offering, Worldwide Events & More
November 12, 2023
Tickers
ATAI
CMPS
CYBN
DRUG
Tags
ENVB
Markets
CMPS
From
Benzinga
Veterans Day: Can Psychedelic Treatment Help Stem PTSD-Related Suicides Among Veterans?
November 11, 2023
Tags
Market News
Markets
Cannabis
From
Benzinga
Cybin Launches Five-Day Units Offering For Up To $64M, Suspends Prior LPC Funding Deal
November 10, 2023
Tickers
CYBN
Tags
News
CYBN
Psychedelics
From
Benzinga
Worldwide Psychedelics Events: Miami, Croatia, D.C., France, UK, NY, Oregon, Arizona & SXSW
November 09, 2023
Tags
Management
SXSW
News
From
Benzinga
Canada To Australia: New MDMA & Psilocybin Shipment On Its Way For Legal Therapeutic Market
November 08, 2023
Tickers
PMBHF
Tags
Legal
PMBHF
News
From
Benzinga
Psychedelics Reform In California, Wisconsin, Illinois, Massachusetts & Pennsylvania
November 05, 2023
Tags
Kratom
Psychedelics
Market News
From
Benzinga
MindMed Q3 2023: Financials, Business Funded By 2026 If LSD Pipeline Milestones Achieved
November 03, 2023
Tickers
MNMD
Tags
News
Earnings
MNMD
From
Benzinga
Single Dose Of Cybin's Psilocybin Shows Compelling Patient Outcomes, Phase 2 Results Find
November 01, 2023
Tickers
CYBN
Tags
CYBN
News
Markets
From
Benzinga
Ketamine Company Acquisition Alert: Beckley Waves Adds Nue Life To Its Portfolio
October 26, 2023
Tags
Beckley Waves
Markets
Ketamine/Assisted Therapy
From
Benzinga
EXCLUSIVE: Becoming Compliant In Today's Legal Psychedelics Markets With Allay Consulting
October 26, 2023
Tags
Interview
Regulations
Allay Consulting
From
Benzinga
Cybin Officially Owns Small Pharma: Plans For New 'International Leader' In Psychedelic Therapeutics
October 23, 2023
Tickers
CYBN
DMTTF
Tags
News
Psychedelics
Psychedelics Research
From
Benzinga
Psyched: Jada Pinkett-Smith's Ayahuasca Journey, RIP Dr. Roland Griffiths, Congressional VA Hearings Halted
October 22, 2023
Tickers
ATAI
CMPS
CYBN
DMTTF
Tags
HUGE
IXHL
ATAI
From
Benzinga
Psychedelics Decriminalization In California: Eureka City Council Latest To Pass Resolution
October 22, 2023
Tags
News
Psychedelics Reform
Regulations
From
Benzinga
Orange Photonics: New High-Tech Testing For Psychedelic Products
October 20, 2023
Tags
Psychedelic/Assisted Therapies
psilocybin mushrooms
Benzinga
From
Benzinga
Small Pharma's Q2 2024 Financial Highlights Ahead Of Cybin Merger For Global DMT Business
October 20, 2023
Tickers
CYBN
DMT
DMTTF
Tags
Psychedelics
Psychedelic/Assisted Therapies
Penny Stocks
From
Benzinga
Congress Halts Hearing On Psychedelics & Veterans As House Speaker Drama Continues
October 20, 2023
Tags
Psychedelic/Assisted Therapies
Benzinga
FDA
From
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
14
15
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.